Baird's Investment Banking Group is pleased to announce the following transaction:

Date:
December 2021
Company:
TLGY Acquisition Corporation
Description:
Initial Public Offering
Sector(s):
Healthcare
Baird served as lead manager on this offering
$230.000 Million

TLGY Acquisition Corporation (“TLGY” or the “Company”), a special purpose acquisition company, recently completed an upsized initial public offering of 23,000,000 units, including the exercise in full of the underwriters' option to purchase an additional 3,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $230 million. The Company intends to use the net proceeds from this offering to effect a future business combination.

TLGY is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. While the Company may pursue an acquisition or business combination target in any business or industry, it intends to focus its search on the global biopharma or technology enabled business-to-consumer (“B2C”) industries. TLGY is led by Jin-Goon Kim, a former partner of TPG Capital and a former CEO of industry leaders in Asia, including Dell Korea and Li Ning. Jin-Goon Kim is joined by Co-Presidents, Dr. Theron Odlaug, who has more than 40 years of experience as a CEO, Board Member and Senior Executive of pharmaceutical and allied companies, and Steven Norman, who has more than 20 years of experience as an executive and a director in the Asia-Pacific technology space.

For additional information about this transaction, please contact:

Derrick Li +1-917-717-0994
Justin Holsen +1-414-298-7768
Lance Lange +1-414-765-7079
Ryan Engelhardt +1-414-298-2637
Michael Kim +1-312-609-4482
Matt Gailey +1-414-765-1458